News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Staff Spotlight: Meet PCI’s Newest Team Members
Meet PCI's newest staff members and read their bios.
The Future of Research-Based Innovation Hubs with the Rise of Remote Work
John Swartley and Bhavana Mohanraj discuss how working remotely will impact research and innovation hubs.
Car-T Pioneer Bruce Levine Speaks on the Past, Present and Future of Cancer Therapy
Learn about Dr. Bruce Levine's predictions for the future uses of Car-T therapy.
Penn ICorps Graduate and President’s Innovation Prize Winner Strella Biotech Raises $8 Million in Series A Funding Round
Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.
Gnubiotics and Penn Explore CAR-T Therapy
This collaboration will take place through company-sponsored pre-clinical research studies in the laboratory of Avery Posey, PhD, an assistant professor at the Perelman School of Medicine.
Penn Medicine Co-Investment Program continues to thrive
Fiscal year 2022 saw the Co-Investment Program help launch and fund 2 new companies ViTToria Biotherapeutics and Dispatch Bio, as well as participate in follow-on rounds for Linnaeus Therapeutics, Car
Penn Spinout Regenxbio Opens New Gene Therapy Manufacturing Facility in Maryland
Regenxbio, a gene therapy company founded through collaboration with PCI, opened a new facility at its Maryland campus.
Five Years of Data Show Long-term Promise for Penn and Novartis’ Car-T Pioneer Kymriah
Five years after Penn and Novartis made history with the FDA approval of Kymriah, a recent study shows the long-term impact of the medication on patient remission rates.
Penn Partners with PaxeraHealth to Build AI Algorithms for Ultrasound Research
The collaboration between Penn and PaxeraHealth will concentrate on developing imaging algorithms to detect liver cancer in addition to covid detection via lung ultrasounds.
Penn to Use Covid-19 Vaccine Royalties to Fund Further Scientific and Medical Research
Covid-19 vaccine royalties from Karikó and Weissman's research are being re-invested into Penn’s research portfolio to support further discovery of life-saving therapies and technologies.